Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:07 PM
Ignite Modification Date:
2025-12-24 @ 3:07 PM
NCT ID:
NCT00359892
Eligibility Criteria:
Inclusion Criteria:
* Pathological confirmation of Hodgkin's Lymphoma.
* Must have measurable disease.
* Evidence of progressive disease following at least one prior line of combination therapy.
* Must have failed, refused, or otherwise not a candidate for stem cell transplant.
* Patient's must have normal organ function.
* Willing to submit to blood sampling for planned PK and PD analyses.
* Ability to understand and willingness to sign a written informed consent form.
Exclusion Criteria:
* No other agents or therapies administered with the intent to treat malignancy.
* Patients with prior exposure to obatoclax.
* Prior allogeneic stem cell transplant if evidence of graft versus host disease, or requirement for steroids or other immunosuppressive therapy.
* Uncontrolled, intercurrent illness.
* Pregnant women and women who are breast feeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00359892
Study Brief:
Protocol Section:
NCT00359892